id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2017-N-6381-0008,FDA,FDA-2017-N-6381,Postmarketing Safety Reports for Approved New Animal Drugs; Electronic Submission Requirements - FRIA,Other,Assessment Document or Analysis,2020-10-01T04:00:00Z,2020,10,2020-10-01T04:00:00Z,,2020-10-01T15:59:41Z,,0,0,09000064847c5f5d
FDA-2017-N-6381-0013,FDA,FDA-2017-N-6381,FDA tab B - Postmarket Safety Reports for NAD - RIA (OMB redline compare 3-18-20 to 6-11-20) RE Memorandum to DMS - Postmarketing Safety Reports for Approved New Animal Drugs; Electronic Submission Requirements (Final Rule),Supporting & Related Material,Background Material,2020-10-01T04:00:00Z,2020,10,,,2020-10-01T18:19:41Z,,0,0,09000064848af132
FDA-2017-N-6381-0011,FDA,FDA-2017-N-6381,FDA tab A - Postmarket Safety Reports for NAD - RIA (OMB preliminary 3-18-20) RE Memorandum to DMS - Postmarketing Safety Reports for Approved New Animal Drugs; Electronic Submission Requirements (Final Rule),Supporting & Related Material,Background Material,2020-10-01T04:00:00Z,2020,10,,,2020-10-01T18:19:22Z,,0,0,09000064848ae7c8
FDA-2017-N-6381-0009,FDA,FDA-2017-N-6381,Memorandum to DMS - Postmarketing Safety Reports for Approved New Animal Drugs; Electronic Submission Requirements (Final Rule),Other,Memorandum,2020-10-01T04:00:00Z,2020,10,2020-10-01T04:00:00Z,,2020-10-01T18:10:24Z,,0,0,09000064848ae7c5
FDA-2017-N-6381-0010,FDA,FDA-2017-N-6381,FDA tab A - Postmarket Safety Reports for NAD - Final Rule (2018-333) (OMB preliminary 3-18-20) RE Memorandum to DMS - Postmarketing Safety Reports for Approved New Animal Drugs; Electronic Submission Requirements (Final Rule),Supporting & Related Material,Background Material,2020-10-01T04:00:00Z,2020,10,,,2020-10-01T18:19:12Z,,0,0,09000064848ae7c7
FDA-2017-N-6381-0015,FDA,FDA-2017-N-6381,FDA tab C - Postmarket Safety Reports for NAD - RIA (OMB final 6-11-20) RE Memorandum to DMS - Postmarketing Safety Reports for Approved New Animal Drugs; Electronic Submission Requirements (Final Rule),Supporting & Related Material,Letter,2020-10-01T04:00:00Z,2020,10,,,2020-10-01T18:20:15Z,,0,0,09000064848af134
FDA-2017-N-6381-0012,FDA,FDA-2017-N-6381,FDA tab B - Postmarket Safety Reports for NAD - Final Rule (OMB redline compare 3-18-20 and 6-11-20) RE Memorandum to DMS - Postmarketing Safety Reports for Approved New Animal Drugs; Electronic Submission Requirements (Final Rule),Supporting & Related Material,Background Material,2020-10-01T04:00:00Z,2020,10,,,2020-10-01T18:19:30Z,,0,0,09000064848af131
FDA-2017-N-6381-0014,FDA,FDA-2017-N-6381,FDA tab C - Postmarket Safety Reports for NAD - Final Rule (2018-333) (OMB final 6-11-20) RE Memorandum to DMS - Postmarketing Safety Reports for Approved New Animal Drugs; Electronic Submission Requirements (Final Rule),Supporting & Related Material,Background Material,2020-10-01T04:00:00Z,2020,10,,,2020-10-01T18:19:56Z,,0,0,09000064848af133
FDA-2017-N-6381-0007,FDA,FDA-2017-N-6381,Postmarketing Safety Reports for Approved New Animal Drugs; Electronic Submission Requirements; Correction,Rule,Correction,2020-09-22T04:00:00Z,2020,9,2020-09-22T04:00:00Z,,2020-09-22T12:37:08Z,2020-18263,0,0,090000648486e736
FDA-2017-N-6381-0006,FDA,FDA-2017-N-6381,"Agency Information Collection Activities; Announcement of Office of
Management and Budget Approvals",Notice,Notice of Approval,2020-08-31T04:00:00Z,2020,8,2020-08-31T04:00:00Z,,2020-08-31T12:51:51Z,2020-19092,0,0,090000648482d0bc
FDA-2017-N-6381-0005,FDA,FDA-2017-N-6381,Postmarketing Safety Reports for Approved New Animal Drugs; Electronic Submission Requirements,Rule,Final Rule,2020-07-29T04:00:00Z,2020,7,2020-07-29T04:00:00Z,,2020-08-31T17:18:31Z,2020-15441,0,0,09000064847b35cc
FDA-2017-N-6381-0002,FDA,FDA-2017-N-6381,Docket No FDA-2017-N-6381 PRIA - ADE Mandatory Electronic Submission NPRM - Feb 14 2018,Other,Report,2018-02-14T05:00:00Z,2018,2,2018-02-14T05:00:00Z,,2018-02-14T16:00:16Z,,0,0,0900006482f31359
FDA-2017-N-6381-0001,FDA,FDA-2017-N-6381,Postmarketing Safety Reports for Approved New Animal Drugs; Electronic Submission Requirements,Proposed Rule,Notice of Proposed Rulemaking (NPRM),2018-02-14T05:00:00Z,2018,2,2018-02-14T05:00:00Z,2018-05-01T03:59:59Z,2018-04-26T01:05:34Z,2018-02757,0,0,0900006482f30507